Journal of Pregnancy and Neonatal Medicine

All submissions of the EM system will be redirected to Online Manuscript Submission System. Authors are requested to submit articles directly to Online Manuscript Submission System of respective journal.
Reach Us +441518081136

Mini Review - Journal of Pregnancy and Neonatal Medicine (2023) Volume 7, Issue 5

Neonatal sepsis: Diagnosis, treatment, and prognosis.

Sherin Varkey *

Sanquin Blood Supply Foundation, the Netherlands

*Corresponding Author:
Sherin Varkey
Sanquin Blood Supply Foundation, the Netherlands
E-mail: varkeys77@netherland.com

Received: 26-Sept-2023, Manuscript No. AAPNM-23-115938; Editor assigned: 27-Sept-2023, PreQC No. AAPNM-23-115938; Reviewed: 11-Oct-2023, QC No. AAPNM-23-115938; Revised: 16-Oct-2023, Manuscript No. AAPNM-23-115938(R); Published: 23-Oct-2023, DOI:10.35841/aapnm -7.5.166

Citation: Varkey S. Neonatal sepsis: Diagnosis, treatment, and prognosis. J Preg Neonatal Med. 2023;7(5):166

Visit for more related articles at Journal of Pregnancy and Neonatal Medicine

Introduction

Neonatal sepsis occurs when bacteria, viruses, fungi, or other pathogens enter a baby's bloodstream, often through the birth process, and cause a systemic infection. Neonates have underdeveloped immune systems, making them particularly susceptible to infections. Sepsis can be classified as early-onset or late-onset, depending on when it develops [1].

Early-Onset Sepsis: This typically occurs within the first 72 hours of life and is often associated with maternal infections that can be transmitted to the baby during childbirth. Group B Streptococcus (GBS) and Escherichia coli (E. coli) are common causative agents. Late-Onset Sepsis: Late-onset sepsis occurs after the first week of life, often as a result of healthcare-associated infections, invasive medical procedures, or environmental exposure. Pathogens such as Staphylococcus and Klebsiella are frequently implicated [2].

Neonatal sepsis is a medical emergency that requires immediate treatment. Treatment typically involves: Antibiotics: Broad-spectrum antibiotics are administered intravenously to combat the infection. The choice of antibiotics may be adjusted once the specific pathogen is identified through blood culture results. Supportive Care: Infants with sepsis often require supportive care, including intravenous fluids, respiratory support (such as supplemental oxygen or mechanical ventilation), and other treatments to stabilize vital signs and maintain organ function [3].

Management of Complications: Neonatal sepsis can lead to various complications, such as organ dysfunction or disseminated intravascular coagulation (DIC). Healthcare providers manage these complications as they arise. Close Monitoring: Infants with sepsis are closely monitored in neonatal intensive care units (NICUs). Monitoring includes frequent assessments of vital signs, laboratory tests, and imaging studies to track the progress of treatment [4].

In general, with timely diagnosis and appropriate treatment, many infants with neonatal sepsis can recover and go on to lead healthy lives. However, it is essential for parents and healthcare providers to remain vigilant for potential complications and provide comprehensive care and support to affected infants throughout their developmental years [5].

Conclusion

Neonatal sepsis is a serious and potentially life-threatening condition that requires immediate attention and treatment. Early diagnosis, prompt initiation of antibiotics, and comprehensive care in a neonatal intensive care unit are essential for improving the prognosis of affected infants. As medical knowledge and technology continue to advance, the outlook for neonatal sepsis is improving, offering hope for the tiniest patients and their families.

References

  1. Tita AT, Andrews WW. Diagnosis and management of clinical chorioamnionitis. Clin Perinatol. 2010;37(2):339-54.

    2. Indexed at, Google Scholar, Cross Ref

  2. Coggins SA, Glaser K. Updates in Late-Onset Sepsis: Risk Assessment, Therapy, and Outcomes. Neoreviews. 2022;23(11):738-55.

    3. Indexed at, Google Scholar, Cross Ref

  3. Gunnink SF, Vlug R, Fijnvandraat K, et al. Neonatal thrombocytopenia: etiology, management and outcome. Expert Rev Hematol. 2014;7(3):387-95.

    4. Indexed at, Google Scholar, Cross Ref

  4. Carbone F, Montecucco F, Sahebkar A. Current and emerging treatments for neonatal sepsis. Expert Opin Pharmacother. 2020;21(5):549-56.

    5. Indexed at, Google Scholar, Cross Ref

  5. Cohen-Wolkowiez M, Benjamin Jr DK, Capparelli E. Immunotherapy in neonatal sepsis: advances in treatment and prophylaxis. Curr Opin Pediatr. 2009;21(2):177-81.

    6. Indexed at, Google Scholar, Cross Ref

Get the App